Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 326 publications.

Lau DT, Morlock R, Hill CD. Psychometric evaluation of the medical outcomes study-sleep scale in persons with overactive bladder. Clin Ther. 2006 Dec 29;28(12):2119-32.

Rothman KJ, Arellano FM, Young-Xu Y, Simonsen L. Reply to gargiullo et Al. J Infect Dis. 2006 Dec 15;194(12):1794-5.

Hauber AB, Johnson FR, Andrews EA. Risk-benefit analysis methods for pharmaceutical decision-making - Where are we now? Ispor Connections. 2006 Dec 15;12(6):3-5.

Bridges JFP, Onukwugha E, Johnson FR, Hauber AB. Patient preference methods – a patient-centered evaluation paradigm. Ispor Connections. 2006 Dec 15;13(6):4-7.

Brogan AP, Dickerson TJ, Janda KD. Enamine-based aldol organocatalysis in water: are they really "all wet"? Angew Chem Int Ed Engl. 2006 Dec 11;45(48):8100-2.

Rothman KJ, Arellano FM, Young-Xu Y, Simonsen L. Reply to "is there a safe age for vaccinating infants with tetravalent rhesus-human reassortant rotavirus vaccine?". J Infect Dis. 2006 Dec;194(12):1793-4.

Mangel AW, Fehnel SE. Adequate relief in IBS treatment trials: corrections to errors stated by Whitehead et al. Am J Gastroenterol. 2006 Dec;101(12):2884-5.

Greiner W, Lehmann K, Earnshaw S, Bug C, Sabatowski R. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany. Eur J Health Econ. 2006 Dec 1;7(4):290-6.

Seeger JD, West WA, Fernandez C, Rivero E. Pregnancy and pregnancy outcome among women with inflammatory skin diseases. Dermatology. 2006 Dec 1;214(1):32-9.

Perez-Gutthann S, Cook S, Dai W, Hirst C, Andrews E. A call for international harmonization in therapeutic risk management. Pharmacoepidemiol Drug Saf. 2006 Dec 1;15(12):839-49.

Tang P, Wang X, Schiffhauer L, Wang JM, Bourne P, Yang Q, Quinn A, Hajdu SI. Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers. Ann Clin Lab Sci. 2006 Dec 1;36(1):16-22.

Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ. Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiol Drug Saf. 2006 Dec 1;15(12):861-72.

Sansom S, Lasry A, Hicks KA. The optimal allocation of HIV prevention dollars. Presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.

Sunyer J, Jarvis D, Gotschi T, Garcia-Esteban R, Jacquemin B, Aguilera I, Ackerman U, de Marco R, Forsberg B, Gislason T, Heinrich J, Norback D, Villani S, Kunzli N. Chronic bronchitis and urban air pollution in an international study. Occup Environ Med. 2006 Dec;63(12):836-43. doi: 10.1136/oem.2006.027995

Long S, Argyle DJ, Nixon C, Nicholson I, Botteron C, Olby N, Platt S, Smith K, Rutteman GR, Grinwis GC, Nasir L. Telomerase reverse transcriptase (TERT) expression and proliferation in canine brain tumours. Neuropathol Appl Neurobiol. 2006 Dec;32(6):662-73.

Hicks KA. A model for the efficient allocation of hiv prevention resources. Poster presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.

Hicks KA. Making use of cost-effectiveness analysis in the community planning process: methods and tools. Presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.

Sorensen HT, Pedersen L, Norgaard M, Rothman KJ, Lash TL. No excess risk of breast cancer in mothers of boys with hypospadias. Epidemiology. 2006 Nov 30;17(6):706-7.

Earnshaw SR, Joshi AV, Wilson MR, Rosand J. Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Stroke. 2006 Nov 28;37(11):2751-8.

Willich SN, Brüggenjürgen B, McBride DW, Hecke T, Straub C, Kuck KH. Medikament-freisetzende versus konventionelle stents - gershwin (german stent health outcome and economics within normal practice). Dtsch Arztebl. 2006 Nov 18;102(46):3180-5.

Gonzalez-Perez A, Fernandez-Vidaurre C, Rueda A, Rivero E, Garcia-Rodriguez LA. Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf. 2006 Nov 15;15(2):131-8.

Stull DE. Impact of congestion associated with allergic rhinitis on sleep, daytime somnolence and fatigue, and work and school productivity. Poster presented at the annual meeting of the American College of Allergy, Asthma, and Immunology; November 11, 2006. Philadelphia, PA.

Stull DE, Krouse J, Naclerio R, Meltzer E, Long A, Lund V. Development and validation of the congestion quantifier 5-item (CQ5): a screening tool for nasal congestion. Presented at the annual meeting of the American College of Allergy, Asthma, and Immunology; November 11, 2006. Philadelphia, PA.

Mauskopf JA, Brogan AJ, Smets E, Martin S. Cost-effectiveness of darunavir (TMC114)/ritonavir compared with currently available protease inhibitors in treatment-experienced HIV patients. Poster presented at the 8th International Congress on Drug Therapy in HIV Infection; November 2006.

Garcia-Esteban R, Sunyer J, Torrent M, Ribas-Fito N, Carrizo D, Grimalt JO, Anto JM. Early exposure to DDE and asthma. Poster presented at the International Conference on Environmental Epidemiology & Exposure (ISEE/ISEA); November 2006. Paris, France. [abstract] Epidemiology. 2006 Nov; 17(6):S281-2.

Zhou X, Radigue C, Allshouse AA, Gilsenan A. In Europe, how representative are overweight/obese subjects recruited via the internet? Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A326.

Javitt JC, Wolowacz SE, Roskell NS, Maciver F, Kelly S, Pleil AM, Zlateva GP. Cost-effectiveness of pegaptanib in age-related macular degeneration: the impact of differences between USA and UK health care systems. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A370.

Wolowacz SE, Roskell NS, Maciver F, Kelly S. Cost-utility analysis for pegaptanib in age-related macular degeneration in the UK: the impact of demographic and disease characteristics. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A370.

Sorensen HT, Lash T, Rothman KJ. Beyond randomized controlled trials. A critical comparison of trials with non-randomized studies. Hepatology. 2006 Nov;44(5):1075-82. doi: 10.1002/hep.21404

Burch SP, Davis KH, Fehnel SE, Nelsen AC, Hill CD, Shashidhar KH. Outcomes, impact and behavior associated with acute treatment of migraine. Poster presented at the 16th Migraine Trust International Symposium; November 2006. [abstract] Cephalalgia. 2006 Nov; 26(11):1358-403.

Earnshaw SR, Wilson MR, Joshi AV. Budgetary impact analysis of recombinant activated factor vii in the treatment of intracerebral hemorrhage: a US health plan perspective. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A329.

Earnshaw SR, Joshi AV, Wilson MR, Rosand J. Cost-effectiveness of recombinant activated factor vii in the treatment of intracerebral hemorrhage. Poster presented at the 2006 International Stroke Conference; February 17, 2006. [abstract] Stroke. 2006 Nov; 37(11):2751.

Earnshaw SR, Graham CN, Amonkar MM, Poston SA, Barr CE. Cost-effectiveness of ibandronate intravenous injection in the treatment of US women with postmenopausal osteoporosis. Poster presented at the 2006 American College of Rheumatology Scientific Meeting; November 2006.

Earnshaw SR, Pignone M, Tice J, Pletcher M. Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Poster presented at the Annual Meeting of the Institute for Operations Research and the Management Sciences; November 2006.

Cowell W, Amonkar M, Cooper A, Earnshaw SR, Beard SM, Lynch N, Middelhoven H. Ibandronate vs. alendrolate: a cost-effectiveness analysis using persist results. Poster presented at the 2006 American College of Rheumatology Scientific Meeting; November 2006.

Maxwell GL, Schildkraut JM, Calingaert B, Risinger JI, Dainty L, Marchbanks PA, Berchuck A, Barrett JC, Rodriguez GC. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk. Gynecol Oncol. 2006 Nov 1;103(2):535-40.

Mathews R, Leiss J, Vanderpuije A. Completion of high school among teenage mothers in North Carolina: a prospective study using maternally linked birth records. Poster presented at the 134th Annual Meeting of the American Public Health Association; November 2006.

Kercher K, Kosloski K, Stull DE, Van Dussen DJ. Evaluating the relationship between self-rated health and depression using an accelerated growth curve model. Poster presented at the 59th annual meeting of the Gerontological Society of America; November 2006.

Sexton JB, Makary MA, Tersigni AR, Pryor D, Hendrich A, Thomas EJ, Holzmueller CG, Knight AP, Wu Y, Pronovost PJ. Teamwork in the operating room: frontline perspectives among hospitals and operating room personnel. Anesthesiology. 2006 Nov;105(5):877-84.

Heurta C, Castellsague J, Garcia Rodriquez LA, Varas-Lorenzo C. Nonsteroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population. Heart. 2006 Nov;92(11):1610-5.

Sawicki GS, Rasouliyan L, Pasta DJ, Regelmann WE, Wagener JS, Waltz DA, Ren CL, Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Pediatr Pulmonol. 2006 Nov;43(11):1117-23. doi: 10.1002/ppul.20914

Zinner N, Black L, Seifelden R, Rasouliyan L. Impact of solifenacin on health utility, work productivity, and medical care utilization. Poster presented at the Congress of the Societe Internationale d'Urologie; November 2006. Cape Town, South Africa.

Lee WC, Joshi AV, Brown TM, Hadker N, Sumner M, Pashos CL. Physicians' preferences toward coagulation factor concentrates in the treatment of hemophilia patients with inhibitors: a discrete choice experiment. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; October 2006. [abstract] Value Health. 2006 Nov; 9(6):A251.

Borish L, Campbell J, Rasouliyan L, Haselkorn T, Lee JH, Wenzel SE. Widely variant asthma control in a cohort of severe or difficult-to-treat asthmatics treated with different regimens of inhaled corticosteroids and long-acting beta-agonists. Poster presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting; November 2006. Philadelphia, PA.

Mast TC, DeMuro-Mercon CJ, HPV Psychosocial Team. Describing the psychosocial burden of illness among women experiencing human papillomavirus-related illness or screening interventions. Poster presented at the 18th World Congress of the International Federation of Gynecology and Obstetrics; November 2006.

Bernardo M, Globe D, Kewalramani R, Masaquel CJ. Costs of anemia management in chronic disease (CKD) from the perspective of the payor, patient, and family. Poster presented at the American Society of Nephrology; November 2006.

Meads DM, McKenna SP, Doward LC. Assessing the cross-cultural comparability of the Centre for Epidemiologic Studies Depression scale (CES-D). Poster presented at the 2006 ISPOR 9th Annual European Congress; October 2006. Copenhagen, Denmark. [abstract] Value Health. 2006 Nov; 9(6):A324.

Johnson FR, Ozdemir S, Mansfield CA, Hass S, White J. Are Adults More Averse to Treatment Risks for Their Children Than They Are for Themselves? Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006.

Wolowacz SE. The National Institute for Health and Clinical Excellence (NICE) Single Technology Appraisal (STA) process: an update on the first round of submissions. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006.

Candrilli SD, Davis KL, Joshi AV, Tortella BJ. Healthcare utilization and costs associated with blunt and penetrating trauma in a United States managed care population. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006.